
PepGen Shares Positive 5 mg/kg Phase 2 FREEDOM2 Results Showing Strong Safety and Activity
PepGen Reports Positive Topline Results from Lowest-Dose (5 mg/kg) MAD Cohort in Phase 2 FREEDOM2 Study, Highlighting Safety, Splicing, and vHOT Outcomes PepGen has reported encouraging topline results from the…












